Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Jun / Aim for the Stars
Oncology Analytical science Oncology Software and hardware Technology and innovation

Aim for the Stars

How algorithms designed to map the universe can help optimize cancer diagnosis and treatment

By Michael Schubert 06/03/2021 Quick Read (pre 2022) 1 min read

Share

Celestial object-mapping algorithms are typically used to determine the distance between galaxies and stars across the universe. But could their applications stretch beyond the stars? A new tool translates these algorithms to life sciences research by examining cells and the distances between them at microscopic levels. Why? To explore the immune landscape of cancer in a rapid, intelligent fashion – the same way we explore the landscape of the sky. More specifically, the program analyzes large multiplexed immunofluorescence (mIF) datasets by using celestial object-mapping algorithms to rapidly identify optimized predictive signatures.

The AstroPath database contains billions of data objects – large cohorts of tissue samples and images and their associated clinical outcomes data. The algorithm enables scientists to ask hypothesis-driven questions and get answers in milliseconds. How? Using a specially designed data structure (for both hardware and software) that allows rapid querying of whole study cohorts, looking for patterns that correlate with clinical parameters, such as treatment response.

Leveraging the techniques used in astronomy, these deep learning algorithms can help us better understand the relationships between cells (including rare cells) and their densities as well as how they relate to tumors. In the future, we may be able to use this information to gain deeper insights into biomarkers and improve personalized treatment decision-making.

Establishing an mIF workflow in the lab is a first critical step for analyzing spatial phenotypic signatures. Once the workflow exists, the new spatial phenotypic signatures – discovered through AstroPath and captured as new algorithms – can be applied in a conventional lab workflow as fit-for-purpose R scripts or through similar software applications. So far, such algorithms have been applied extensively to melanoma samples with promising results. Now being studied in other cancer types, these spatial phenotypic signatures are showing potential as new biomarker signatures in immuno-oncology.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Michael Schubert

While obtaining degrees in biology from the University of Alberta and biochemistry from Penn State College of Medicine, I worked as a freelance science and medical writer. I was able to hone my skills in research, presentation and scientific writing by assembling grants and journal articles, speaking at international conferences, and consulting on topics ranging from medical education to comic book science. As much as I’ve enjoyed designing new bacteria and plausible superheroes, though, I’m more pleased than ever to be at Texere, using my writing and editing skills to create great content for a professional audience.

More Articles by Michael Schubert

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Opening a Window into Brain Trauma
Analytical science
Opening a Window into Brain Trauma

January 18, 2024

4 min read

Raman spectroscopy shows promise as the first point-of-care diagnostic device for TBI

Could ≠ Should
Analytical science
Could ≠ Should

January 20, 2022

1 min read

The need to prevent the ordering of unnecessary tests

Diamonds Are a Diagnostician’s Best Friend
Analytical science
Diamonds Are a Diagnostician’s Best Friend

February 8, 2022

1 min read

A diagnostic sensor for rapid, cost-effective, and accurate detection of SARS-CoV-2

Hunting the Unknown
Analytical science
Hunting the Unknown

February 22, 2022

1 min read

When it comes to human health, we cannot ignore unknown molecules simply because they present analytical challenges

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.